At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 122 enrolled
Drug / intervention
Gabapentin +1 moredrug
Likely dose
Gabapentin 300 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Persistent Postoperative Pain Incidence With Long Term Perioperative Gabapentin Used
In Brief
A Phase 4 clinical trial evaluating Gabapentin and Placebo for Pain, Postoperative. Completed, enrolled 122 participants across 1 site.
Detailed Summary
The study's objective will be to evaluate the gabapentine efficiency in orally and long term used after painfully surgeries.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative
CountriesArgentina
Collaborators--
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartDec 2015
Primary CompletionJan 2016
First PostedFeb 2016
Study CompletionJun 2022
TodayJul 2026
First PostedFeb 29, 2016
Enrollment StartDec 1, 2015
Primary CompletionJan 1, 2016
Study CompletionJun 1, 2022
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 10.3 years ago
Interventions
Gabapentindrug
gabapentin 300 mg per day, orally during 30 days
Placebodrug
Placebo 300 mg per day, orally during 30 days